【24h】

Vasomotor rhinitis.

机译:血管舒缩性鼻炎。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Vasomotor rhinitis affects millions of Americans and results in significant symptomatology. Characterized by a combination of symptoms that includes nasal obstruction and rhinorrhea, vasomotor rhinitis is a diagnosis of exclusion reached after taking a careful history, performing a physical examination, and, in select cases, testing the patient with known allergens. According to a 2002 evidence report published by the Agency for Healthcare Research and Quality (AHRQ), there is insufficient evidence to reliably differentiate between allergic and nonallergic rhinitis based on signs and symptoms alone. The minimum level of diagnostic testing needed to differentiate between the two types of rhinitis also has not been established. An algorithm is presented that is based on a targeted history and physical examination and a stepwise approach to management that reflects the AHRQ evidence report and U.S. Food and Drug Administration approvals. Specific approaches to the management of rhinitis in children, athletes, pregnant women, and older adults are discussed.
机译:血管舒缩性鼻炎影响数以百万计的美国人,并导致明显的症状。血管舒缩性鼻炎的特征在于包括鼻塞和鼻漏,这些症状的综合表现是经过仔细的病史,进行了体格检查以及在某些情况下用已知的过敏原对患者进行了检查,从而排除了血管舒缩性鼻炎。根据美国医疗保健研究与质量局(AHRQ)发布的2002年证据报告,没有足够的证据可靠地仅根据症状和体征区分过敏性和非过敏性鼻炎。尚未确定区分两种鼻炎所需的最低诊断水平。提出了一种算法,该算法基于有针对性的病史和体格检查,以及一种逐步反映AHRQ证据报告和美国食品药品管理局批准的管理方法。讨论了处理儿童,运动员,孕妇和老年人鼻炎的具体方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号